| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-09 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.0009 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |